2019 Research Highlight

PSA screening - for whom and when?
Peter Albers
Asian J Androl : 3-5; 10.4103/aja.aja_37_17
Abstract |Full Text | PDF [2117]

Current and emerging trends in prostate cancer immunotherapy
Adam Schatz, Badar M Mian
Asian J Androl : 6-11; 10.4103/aja.aja_52_17
Abstract |Full Text | PDF [2138]

Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
Logan P Rhea1, Brinda Gupta2, Jeanny B Aragon-Ching3
Asian J Androl : 107-108; 10.4103/aja.aja_88_18
Full Text | PDF [1622]